Aurobindo’s generic Adalat CC gets FDA OKThe market size of the product was $95 million for the 12-month period ended May 2021, according to IQVIA data. Slayback names Pete Meyers CFOMeyers most recently served as CFO of Eagle Pharmaceuticals. Camber debuts generic Revatio OS Camber’s sildenafil for oral suspension is indicated to treat pulmonary arterial hypertension or high blood pressure in the lungs. Lupin intros Kerydin generic Branded and generic versions of the product had U.S. sales of $53 million for the year ended May 2021, according to IQVIA data. Lannett rolls out generic of Lescol XL Lannett’s fluvastatin sodium extended-release tablets will be the second generic available of the branded product. FDA clears Amneal’s generic TobraDex IQVIA data for the year ended May 2021 showed annual U.S. sales of TobraDex and its generics was $118 million. AAM report: Medicare plans lag in adopting new generics The Association for Accessible Medicines’ latest report found that Medicare Part D plans are slow to add new generics to their formularies and often place them on nongeneric pricing tiers. Sandoz launches generic Feraheme Sandoz’s ferumoxytol is the first generic high-dose intravenous iron to treat patients with iron deficiency anemia. Aurobindo obtains FDA OK for generic Lioresal Baclofen tablets have a market value of roughly $77 million for the 12 months ended May 2021, according to IQVIA. Xiromed releases generic Nebcin Nebcin and its generics had a market value of $16 million for the 12-month period ended April 2021, according to IQVIA. First Previous 117 118 119 120 121 Next Last
